Multiple myeloma trials in United States
299 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleBiospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 500
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02682667 - No phaseTaking peopleNon-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
- Where
- Buffalo
- Age
- 18 years and over
- People
- 265
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT05312255 - Phase 3Taking peopleA Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
- Where
- Charlotte, Durham, Gainesville, Houston, Lexington, Los Angeles, Louisville, Portland, Seattle, Stony Brook
- Age
- 18 years and over
- People
- 410 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT05730036 · EU 2022-501396-62-00 - Phase 2Taking peopleAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Where
- Grand Forks, Jacksonville
- Age
- 18 years and over
- People
- 220
- Run by
- Mayo Clinic
See details and how to joinNCT05969860 - Phase 2Taking peopleEngaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
- Where
- New Haven, Omaha, Rochester
- Age
- 18 years and over
- People
- 50
- Run by
- Noffar Bar
See details and how to joinNCT06993675 - Phase 3Taking peopleBelantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma
- Where
- La Crosse
- Age
- 18 years to 79 years
- People
- 500
- Run by
- PrECOG, LLC.
See details and how to joinNCT07285239 - No phaseTaking peopleLong-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
- Where
- Bethesda
- Age
- 7 years to 80 years
- People
- 1,000
- Run by
- National Heart, Lung, and Blood Institute (NHLBI)
See details and how to joinNCT00106925 - Phase 1Taking peopleA Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- Where
- Atlanta, Boston, Chapel Hill, Columbus, Dallas, Detroit, Indianapolis, La Jolla, New York, Rochester, Seattle, Winston-Salem
- Age
- 18 years and over
- People
- 317 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT05137054 · EU 2023-506247-42-00 - No phaseNot yet taking people in United StatesWearable Core Body Temperature Monitoring for Early Detection of Cytokine Release Syndrome in Outpatients Receiving CAR T-Cell Therapy
- Where
- Charlotte, Winston-Salem
- Age
- 18 years and over
- People
- 105
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07911540 - No phaseTaking peopleCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Where
- Aberdeen, Aitkin, Akron, Albert Lea, Albuquerque, Allentown, Alma, Alpena, Alton, Amarillo, Ames, Anaconda, Anchorage, Anderson, Ankeny, Ann Arbor, Antigo, Appleton, Arroyo Grande, Asheville, Ashland, Augusta, Aurora, Aventura, Baker City, Bakersfield, Ballwin, Baltimore, Baraboo, Barberton, Bardstown, Barrington, Baton Rouge, Battle Creek, Baxter, Beavercreek, Belfast, Bellingham, Belpre, Bemidji, Bend, Berlin, Bethesda, Bethlehem, Biddeford, Billings, Bismarck, Bloomington, Boardman, Boise, Bolivar, Bonita Springs, Boone, Boulder, Bozeman, Brainerd, Branson, Braselton, Brewer, Brighton, Brownstown, Brunswick, Bryan, Burbank, Burien, Burlington, Burnsville, Caldwell, Cambridge, Canton, Cape Girardeau, Carbondale, Carmichael, Caro, Carson City, Carterville, Carthage, Cary, Cedar Rapids, Centennial, Centerville, Centralia, Chaska, Chelsea, Chesapeake, Chesterfield, Cheyenne, Chicago, Chillicothe, Cincinnati, Clackamas, Clarkston, Clearwater, Clinton, Clinton Township, Clive, Clyde, Cody, Coeur d'Alene, Colorado Springs, Columbia, Columbus, Concord, Coon Rapids, Coos Bay, Corbin, Council Bluffs, Creston, Crosslake, Crystal Lake, Cudahy, Danville, Dayton, Dearborn, Decatur, Deerfield Beach, Deer River, Delaware, Denver, Des Moines, Detroit, Detroit Lakes, Dixon, Downers Grove, Dublin, Duluth, Durango, Durham, East China Township, Easton, East Stroudsburg, Eau Claire, Edgewood, Edina, Edmonds, Effingham, Elgin, Elk Grove, Elmhurst, Elmira, Ely, Emeryville, Emmett, Englewood, Enumclaw, Eureka, Everett, Evergreen Park, Fairbanks, Fargo, Farmington, Farmington Hills, Federal Way, Findlay, Fishersville, Flint, Florence, Fond du Lac, Fort Collins, Fort Dodge, Fort Lauderdale, Fort Myers, Fort Smith, Fort Thomas, Fosston, Franklin, Freehold, Fridley, Fruitland, Gaffney, Gahanna, Gainesville, Galesburg, Garden City, Garner, Georgetown, Germantown, Gladwin, Glen Burnie, Glens Falls, Goldsboro, Grafton, Grand Forks, Grand Island, Grand Rapids, Great Bend, Great Falls, Greeley, Green Bay, Greenville, Greenwood, Greer, Grosse Pointe Woods, Grove City, Hackettstown, Harvey, Havre, Hayward, Hazel Crest, Hazleton, Helena, Henderson, Hendersonville, Hibbing, Hood River, Houma, Houston, Huntington, International Falls, Issaquah, Jackson, Jacksonville, Jamaica, Jamaica Plain, Jamestown, Janesville, Jefferson, Jefferson City, Joplin, Kalamazoo, Kalispell, Kansas City, Kearney, Kennewick, Kenosha, Kettering, Kewanee, Kingman, Lacey, La Crosse, Lakeland, Lakewood, Lancaster, Lansing, Laredo, Las Cruces, Las Vegas, Leavenworth, Lewisburg, Lexington, Libertyville, Lima, Lincoln, Little Rock, Littleton, Livonia, Loma Linda, London, Lone Tree, Long Beach, Longmont, Longview, Loveland, Macomb, Madison, Manchester, Mankato, Mansfield, Maple Grove, Maplewood, Marietta, Marinette, Marion, Marlette, Marrero, Marshalltown, Martinez, Marysville, Mattoon, Meadowbrook, Mechanicsville, Medford, Medina, Merced, Meridian, Metairie, Miami Beach, Midland, Midlothian, Milwaukee, Minneapolis, Minot, Missoula, Moline, Monticello, Moose Lake, Morristown, Mount Pleasant, Mount Sterling, Mount Vernon, Mukwonago, Mullica Hill, Murrells Inlet, Muskegon, Nags Head, Nampa, Napa, Neenah, New Albany, Newark, Newberg, New Brunswick, New London, New Orleans, New Richmond, Newton, New Ulm, New York, Niles, Norfolk, Normal, Norton Shores, Novi, Oakland, Oak Lawn, Ocean Pines, Oconomowoc, Oconto Falls, O'Fallon, Oklahoma City, Olney, Omaha, Ontario, Oregon City, Osage Beach, Oshkosh, Ottawa, Paducah, Pahrump, Papillion, Parker, Park Rapids, Park Ridge, Pekin, Pennington, Peoria, Pequot Lakes, Perrysburg, Peru, Phoenix, Phoenixville, Pine River, Pittsburg, Plant City, Pompton, Pontiac, Portland, Portsmouth, Port Townsend, Post Falls, Pottstown, Princeton, Providence, Pueblo, Racine, Raleigh, Rancho Mirage, Randallstown, Reading, Redmond, Reed City, Reno, Renton, Rhinelander, Richmond, Rio Rancho, Robbinsdale, Rockford, Rocklin, Rockport, Rolla, Royal Oak, Sacramento, Safety Harbor, Saginaw, Saint Cloud, Sainte Genevieve, Saint Joseph, Saint Louis Park, Saint Paul, Salisbury, San Antonio, Sandpoint, Sandstone, Sanford, San Luis Obispo, Santa Cruz, Santa Maria, Santa Rosa, Savannah, Scarborough, Seattle, Sedro-Woolley, Shakopee, Shawano, Sheboygan, Shelton, Sheridan, Silverdale, Sioux Falls, Southfield, South Portland, Spartanburg, Spokane, Spooner, Springfield, Staples, Sterling Heights, Stevens Point, St. Helena, Stillwater, St Louis, Stockton, Stony Brook, St. Petersburg, Sturgeon Bay, Sullivan, Summit, Superior, Tacoma, Tampa, Tawas City, Thief River Falls, Thornton, Tifton, Toledo, Topeka, Towson, Traverse City, Troy, Twin Falls, Two Rivers, Union, Urbana, Vancouver, Vineland, Virginia, Virginia Beach, Waconia, Walla Walla, Walnut Creek, Warren, Warwick, Washington, Washington D.C., Waukee, Waukesha, Waupaca, Wausau, Wauwatosa, Weaverville, West Allis, West Bloomfield, West Branch, West Columbia, West Des Moines, Westerville, West Haven, Westminster, West Reading, Wichita, Wilkes-Barre, Willmar, Wilmington, Winter Haven, Wisconsin Rapids, Woodbury, Woodland, Worthington, Wyandotte, Wyoming, Yakima, Yelm, Yorkville, Youngstown, Ypsilanti, Zanesville
- Age
- 40 years to 75 years
- People
- 2,900
- Run by
- Alliance for Clinical Trials in Oncology
See details and how to joinNCT05334069 - No phaseTaking peoplecfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Where
- Austin, Charleston, Cleveland, Corbin, Duarte, Elizabethtown, Florence, Gainesville, Lexington, Memphis, Miami, Minneapolis, Nashville, New Albany, Paducah, Portland, Rochester
- Age
- 40 years and over
- People
- 7,000
- Run by
- Adela, Inc
See details and how to joinNCT05366881 - Phase 2Taking peopleTesting the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse
- Where
- Anaconda, Baton Rouge, Billings, Bloomington, Canton, Carthage, Cedar Rapids, Coeur d'Alene, Decatur, Eureka, Galesburg, Great Falls, Kalispell, Kewanee, Macomb, Missoula, O'Fallon, Ottawa, Pekin, Peoria, Peru, Post Falls, Princeton, Sandpoint, Springfield, Washington
- Age
- 18 years and over
- People
- 80
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06948084 - Phase 2Taking peopleBCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM)
- Where
- Milwaukee
- Age
- 18 years and over
- People
- 34
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07009899 - Phase 1Taking peopleFT836 CAR T-cell Therapy in Combination With Daratumumab in Patients With Relapsed and/or Refractory Multiple Myeloma
- Where
- Milwaukee
- Age
- 18 years to 80 years
- People
- 12
- Run by
- Medical College of Wisconsin
See details and how to joinNCT07221032 - Phase 3Taking peopleA Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
- Where
- Atlanta, Columbus, Dallas, Houston, New York, Stony Brook
- Age
- 18 years and over
- People
- 915 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07222761 · EU 2024-519504-27-00 - Phase 3Taking peopleA Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
- Where
- Atlanta, Boston, Columbus, Detroit, New York, Phoenix, Rochester, St Louis
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07393282 · EU 2025-523252-31-00 - No phaseEnrolling by invitationGene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies
- Where
- Bethesda
- Age
- 18 years and over
- People
- 1,000
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02473757 - Phase 2Taking peopleA Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Ann Arbor, Atlanta, Birmingham, Chicago, Duarte, Hollywood, Little Rock, Louisville, Nashville, New York, Portland, Rochester, St Louis
- Age
- 18 years and over
- People
- 510 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT04634552 · EU 2023-504581-29-00 - Phase 4Taking peopleA Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- Where
- Atlanta, Boston, Buffalo, Charlotte, Chicago, Detroit, Duarte, Hackensack, Houston, Indianapolis, Milwaukee, Nashville, New Brunswick, New York, Philadelphia, Phoenix, Pittsburgh, Rochester, San Francisco, Stanford, St Louis, Tampa, The Bronx, Westwood
- Age
- 18 years and over
- People
- 295 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05201781 · EU 2023-505530-10-00 - Phase 3Taking peopleA Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- Where
- Ann Arbor, Baltimore, Bethesda, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Clovis, Columbus, Dallas, Detroit, Duarte, Durham, East Brunswick, East Syracuse, Farmington, Fort Belvoir, Gilbert, Grand Rapids, Hershey, Hollywood, Houston, Irvine, Kansas City, Lake Success, Lebanon, Los Alamitos, Los Angeles, Louisville, Lubbock, Maywood, Mineola, Nashville, Newark, New Haven, Newnan, New York, Norfolk, Novi, Omaha, Orlando, Pittsburgh, Providence, Richmond, Salt Lake City, Santa Fe, Shreveport, Southfield, Tacoma, Tucson, Waukee, Weston, Wilmington, Winston-Salem
- Age
- 18 years and over
- People
- 1,590 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05552222 · EU 2023-503442-30-00 - Phase 1Taking peopleA Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
- Where
- Charlotte, Denver, Duarte, Houston, Irvine, New York, Philadelphia, San Francisco
- Age
- 18 years and over
- People
- 180 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT05652335 · EU 2023-503679-12-00 - No phaseTaking peoplePivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
- Where
- Boston, Hackensack, Honolulu, Houston, Louisville
- Age
- 10 years and over
- People
- 210 worldwide
- Run by
- Leuko Labs, Inc.
See details and how to joinNCT06323447 - Phase 2Taking peopleA Study to Evaluate Efficacy and Safety of Ciltacabtagene Autoleucel
- Where
- Charlotte, Cleveland, Iowa City, New York, San Francisco, Tampa, Winston-Salem
- Age
- 18 years to 80 years
- People
- 60 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07149857 · EU 2025-521975-30-00 - Phase 3Taking peopleA Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- Where
- Ann Arbor, Atlanta, Austin, Baltimore, Boston, Brooklyn, Chapel Hill, Cleveland, Dallas, Denver, Duarte, Durham, Farmington, Fort Myers, Houston, Iowa City, Irvine, Jacksonville, Kansas City, Little Rock, Los Angeles, Louisville, Miami, Milwaukee, Mineola, Nashville, New Haven, New York, Philadelphia, Phoenix, Portland, Rochester, Salt Lake City, San Antonio, San Francisco, Tampa, Waukee, Zion
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07258511 · EU 2025-522007-18-00 - Phase 2Taking peopleA Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
- Where
- Beverly Hills, Columbus, Denver, Goodyear, Irvine, Nashville, Palo Alto, Salt Lake City, St Louis
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07589634